InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,320.40
(
0.96%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.81%
)
Bitcoin
68,512.53
(
0.87%
)
Post# of 251935
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Sikmarson

Send PM Follow Ignore
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Sikmarson

Re: None

Wednesday, 12/21/2016 8:30:13 AM

Wednesday, December 21, 2016 8:30:13 AM

Post# of 251935
CALA; BMY: Bristol-Myers Squibb and Calithera Biosciences Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with Calithera’s CB-839 in patients with clear cell renal cell carcinoma (ccRCC).

CALA + 25% premarket

news link
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up